HELX Holdings Information

HELX is an equity ETF with a total of 64 individual holdings. The top holdings are Natera stock at 6.57%, Guardant Health at 6.28%, Krystal Biotech at 5.36%, United Therapeutics at 4.37%, and BridgeBio Pharma at 4.14%.

Total Holdings

Top 10 Percentage

43.95%

Asset Class

Equity

ETF Category

Health

Assets

22.59M

PE Ratio

28.70

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	NTRA	Natera, Inc.	6.57%	7,131
2	GH	Guardant Health, Inc.	6.28%	15,718
3	KRYS	Krystal Biotech, Inc.	5.36%	4,418
4	UTHR	United Therapeutics Corporation	4.37%	1,680
5	BBIO	BridgeBio Pharma, Inc.	4.14%	12,192
6	LGND	Ligand Pharmaceuticals Incorporated	3.89%	3,794
7	INSM	Insmed Incorporated	3.79%	5,932
8	LON: AZN	AstraZeneca PLC	3.35%	3,695
9	KRX: 207940	Samsung Biologics Co.,Ltd.	3.11%	652
10	ADPT	Adaptive Biotechnologies Corporation	3.09%	48,245
11	MEDP	Medpace Holdings, Inc.	3.06%	1,327
12	VRTX	Vertex Pharmaceuticals Incorporated	2.80%	1,435
13	n/a	Cash	2.70%	610,647
14	REGN	Regeneron Pharmaceuticals, Inc.	2.48%	748
15	CTVA	Corteva, Inc.	2.45%	6,904
16	LLY	Eli Lilly and Company	2.43%	593
17	ALNY	Alnylam Pharmaceuticals, Inc.	2.31%	1,687
18	TEM	Tempus AI, Inc.	2.16%	8,726
19	IONS	Ionis Pharmaceuticals, Inc.	1.99%	5,957
20	BNTX	BioNTech SE	1.98%	4,340
21	TWST	Twist Bioscience Corporation	1.90%	7,184
22	TVTX	Travere Therapeutics, Inc.	1.83%	10,129
23	STOK	Stoke Therapeutics, Inc.	1.74%	10,539
24	EBR: ARGX	argenx SE	1.72%	459
25	NBIX	Neurocrine Biosciences, Inc.	1.59%	2,693

Showing 25 of 64 holdings

Subscribe to see the full list

Activate Now

As of Apr 17, 2026